INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Instituto
![Foto de INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)](/img/noimage.png)
![Foto de Oslo University Hospital](/img/noimage_org.png)
Oslo University Hospital
Oslo, NoruegaPublicaciones en colaboración con investigadores/as de Oslo University Hospital (10)
2023
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
2021
-
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality
Journal of Clinical Investigation, Vol. 131, Núm. 23
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2020
-
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Nature Genetics, Vol. 52, Núm. 1, pp. 56-73
2003
-
Isolation and characterization of a new D-galactose-binding lectin from Sambucus racemosa L.
Protein and Peptide Letters, Vol. 10, Núm. 3, pp. 287-293
-
cDNA molecular cloning and seasonal acumulation of an ebulin l-related dimeric lectin of dwarf elder (Sambucus ebulus L.) leaves
International Journal of Biochemistry and Cell Biology, Vol. 35, Núm. 7, pp. 1061-1065